Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

103 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A phase II trial evaluating capecitabine and irinotecan as second line treatment in patients with oesophago-gastric cancer who have progressed on, or within 3 months of platinum-based chemotherapy.
Leary A, Assersohn L, Cunningham D, Norman AR, Chong G, Brown G, Ross PJ, Costello C, Higgins L, Oates J. Leary A, et al. Cancer Chemother Pharmacol. 2009 Aug;64(3):455-62. doi: 10.1007/s00280-008-0893-5. Epub 2008 Dec 23. Cancer Chemother Pharmacol. 2009. PMID: 19104814 Clinical Trial.
103 results